Ketty Peris

1996–2025 年に発表

別表記
Ketty PERIS
237
論文数
19,038
被引用数
76
h 指数
210
i10 指数

被引用数

Ketty Peris の年別被引用数1985 年: 被引用 1 件1992 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 3 件2000 年: 被引用 7 件2001 年: 被引用 8 件2002 年: 被引用 9 件2003 年: 被引用 7 件2004 年: 被引用 20 件2005 年: 被引用 30 件2006 年: 被引用 29 件2007 年: 被引用 44 件2008 年: 被引用 49 件2009 年: 被引用 52 件2010 年: 被引用 54 件2011 年: 被引用 60 件2012 年: 被引用 79 件2013 年: 被引用 81 件2014 年: 被引用 81 件2015 年: 被引用 88 件2016 年: 被引用 80 件2017 年: 被引用 111 件2018 年: 被引用 130 件2019 年: 被引用 329 件2020 年: 被引用 486 件2021 年: 被引用 654 件2022 年: 被引用 621 件2023 年: 被引用 653 件2024 年: 被引用 1,122 件2025 年: 被引用 544 件2026 年: 被引用 12 件1986〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,272 件、この内訳の 15.9%イタリア: 引用元論文 946 件、この内訳の 11.9%ドイツ: 引用元論文 578 件、この内訳の 7.2%イギリス: 引用元論文 452 件、この内訳の 5.7%中国: 引用元論文 402 件、この内訳の 5%スペイン: 引用元論文 398 件、この内訳の 5%フランス: 引用元論文 359 件、この内訳の 4.5%オーストラリア: 引用元論文 265 件、この内訳の 3.3%オランダ: 引用元論文 219 件、この内訳の 2.7%オーストリア: 引用元論文 212 件、この内訳の 2.7%カナダ: 引用元論文 211 件、この内訳の 2.6%スイス: 引用元論文 189 件、この内訳の 2.4%
0%15.9%その他 31.1%

分野

  • Medicine73.9%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Immunology and Microbiology10.2%
  • Engineering1.4%
  • Computer Science0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • その他1.5%

トピック

  • Cutaneous Melanoma Detection and Management10.2%
  • Nonmelanoma Skin Cancer Studies7.6%
  • Dermatology and Skin Diseases7.1%
  • Psoriasis: Treatment and Pathogenesis5.2%
  • AI in cancer detection2.8%
  • Allergic Rhinitis and Sensitization2.8%
  • その他64.3%

共著者

全論文

検索で開く
  1. Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

    著者: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 被引用: 595

  2. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 被引用: 321

  3. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 被引用: 287

  4. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

    著者: , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2019 被引用: 590

  5. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iris Zalaudek, Claus Garbe - European Journal of Cancer 2023 被引用: 267

  6. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

    著者: , , , , , , , , , , , , , , , - JAMA Dermatology 2020 被引用: 279

  7. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Puig, Frank Seebach, Gavin Thurston, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy G. Bowler, Matthew G. Fury - The Lancet Oncology 2021 被引用: 278

  8. Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian Katz, Robert O. Kenet, Harald Kittler, J. Kreusch, Josep Malvehy, Giampiero Mazzocchetti, Margaret Oliviero, Fezal zdemir, Ketty Peris, Roberto Perotti, Ana M. Perusquia, Maria Antonietta Pizzichetta, Susana Puig, Babar Rao, Pietro Rubegni, Toshiaki Saida, Massimiliano Scalvenzi, Stefania Seidenari, Ignazio Stanganelli, Masaru Tanaka, Karin Westerhoff, Ingrid Wolf, Otto Braun‐Falco, Helmut Kerl, Takeji Nishikawa, Klaus Wolff, Alfred W. Kopf - Journal of the American Academy of Dermatology 2003 被引用: 1,204

  9. Pruritus as a Distinctive Feature of Type 2 Inflammation

    著者: , , , , , - Vaccines 2021 被引用: 160

  10. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2020 被引用: 320

  11. Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial

    著者: , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2022 被引用: 75

  12. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2022 被引用: 174

  13. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2020 被引用: 240

  14. European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force ‘Dermatology for cancer patients’ position statement

    著者: , , , , , , , , , , , , , , , , , , - Journal of the European Academy of Dermatology and Venereology 2021 被引用: 99

  15. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ziad Reguiai, Claire Bernier, Camille Leleu, Julien Seneschal, Delphine Staumont-Sallé, Thomas Hubiche, Caroline Jacobzone, Abdallah Khemis, Marie-Noëlle Crépy, Margitta Worm, Andrea Bauer, Sabine Sell, Swarna Ekanayake-Bohlig, Sylvia Pauser, Timo Buhl, Andreas Schwinn, Bernadette Eberlein, Sven Quist, Boris Bauer, Ketty Peris, Maria Teresa Rossi, Maria Fargnoli, Luigi Naldi, Luca Stingeni, Silvia Ferrucci, Irena Walecka-Herniczek, Dorota Krasowska, Aleksandra Lesiak, Aleksandra Okuniewska, Grażyna Pulka, Malgorzata Dyczek, Bartlomiej Kwiek, Rafal Czajkowski, Hanna Myśliwiec, Padma Mohandas, Sandeep Cliff, Richard Warren, Pippa Cousen, Graham Johnston, Richard Woolf, Kim Papp, David Adam, Darryl Toth, Chih-ho Hong, Irina Turchin, Firouzeh Niakosari, Elena Poulos, Jason Rivers, Jason Ohayon, Melinda Gooderham, Milan Tjioe, Thomas Rustemeyer, Marjolein S. de Bruin-Weller, Marie L.A. Schuttelaar, Judith Molhoek, Bert Oosting, Andreas Pinter, Markus Kaspari, Nina Magnolo, Michael Sebastian, Diamant Thaci, Sibylle Schliemann, Peter Radny, Nicolas Leitz, Athanasios Tsianakas, Amir Yazdi, Maria Kamstrup, Mette Sommerlund, Claus Zachariae, Witold Owczarek ほか 20 名 - The Lancet 2024 被引用: 89

  16. Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study

    著者: , , , , , , , - Clinical Drug Investigation 2021 被引用: 87

  17. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline

    著者: , , , , , , , , , , , , , - European Journal of Cancer 2015 被引用: 507

  18. Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 106

  19. Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Clinical Dermatology 2023 被引用: 49

  20. Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline

    著者: , , , , , , , , , , , , - European Journal of Cancer 2015 被引用: 498

  21. Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicentre cohort study*

    著者: , , , , , , , , , , , , , , , , , , , , , , - British Journal of Dermatology 2020 被引用: 172

  22. Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of the American Academy of Dermatology 2020 被引用: 87

  23. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2021 被引用: 107

  24. Targeting IL-4 for the Treatment of Atopic Dermatitis

    著者: , , , - ImmunoTargets and Therapy 2020 被引用: 103